[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368015-105":59,"doc-detail-368015-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-expression-regulation-molecular-targeting-mechanisms-and-therapeutic-applications-of-the-let-7-microrna-family-in-gastric-cancer","Advances in Expression Regulation, Molecular Targeting Mechanisms, and Therapeutic Applications of the Let-7 MicroRNA Family in Gastric Cancer","","Gastric cancer (GC) is a globally prevalent malignant tumor marked by high incidence and mortality. Progress in molecular studies has emphasized microRNAs (miRNAs) as key regulators of GC initiation, progression, and therapeutic response. Aberrant expression of the Let-7 miRNA family influences GC development by targeting multiple signaling pathways and engaging diverse regulatory mechanisms. The review summarizes Let-7 expression patterns, links target gene regulation to GC phenotypes such as proliferation, invasion, and metastasis, and evaluates current Let-7-based intervention strategies to guide improved treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-expression-regulation-molecular-targeting-mechanisms-and-therapeutic-applications-of-the-let-7-microrna-family-in-gastric-cancer/368015/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-expression-regulation-molecular-targeting-mechanisms-and-therapeutic-applications-of-the-let-7-microrna-family-in-gastric-cancer/368015.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the Let-7 microRNA family important in gastric cancer?","Question",{"text":112,"@type":113},"Let-7 members show aberrant expression in gastric cancer, and their dysregulation is linked to disease progression and patient prognosis. They influence GC by targeting multiple molecular pathways and participating in regulatory mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do microRNAs such as Let-7 regulate gastric cancer cell behavior?",{"text":117,"@type":113},"miRNAs bind complementary sites in the 3′-UTR of target mRNAs, leading to inhibition of translation or promotion of mRNA degradation. Through these target gene effects, they affect processes including proliferation, invasion, and metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the article focus on regarding therapeutic applications?",{"text":121,"@type":113},"The review summarizes expression patterns of the Let-7 family in gastric cancer and reviews advances in Let-7-based interventions. It aims to support improved therapeutic strategies and offer insight for biomarkers and targeted treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368015,1791188795,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Tech Science Press  \n| Doi:10.32604/or.2025.067546\u003Cbr>REVIEW |  |\n| --- | --- |\n|  | |\n| Advances in Expression Regulation, Molecular Targeting Mechanisms, and Therapeutic Applications of the Let-7 MicroRNA Family in Gastric Cancer\u003Cbr>Xinke Chai, Shifeng Wu, Qian Shen and Qiulin Huang*\u003Cbr>The First Affiliated Hospital, Department of Gastrointestinal Surgery, Hengyang Medical School, University of South China, Hengyang, 421001, China\u003Cbr>*Corresponding Author: Qiulin Huang. Email: [2018011993@usc.edu.cn](2018011993@usc.edu.cn)\u003Cbr>[Received: 06 May 2025](Received: 06 May 2025); [Accepted: 21 July 2025](Accepted: 21 July 2025); [Published: 27 November 2025](Published: 27 November 2025)\u003Cbr>ABSTRACT: Gastric cancer (GC) is a prevalent malignant tumor globally, with high incidence and mortality rates Advances in understanding molecular mechanisms underlying GC have highlighted the role of microRNAs (miRNAs) in its initiation, progression, and treatment. The Let-7 family, an important class of miRNAs, is closely associated with the biological behaviors of GC. Aberrant expression of various Let-7 family members in GC patients contributes to disease progression, as they target multiple molecular pathways and participate in diverse regulatory mechanisms throughout GC pathogenesis. This article systematically summarizes the expression patterns of Let-7 family members in GC, explores their influence on GC cell behaviors such as proliferation, invasion, and metastasis through key target gene regulation, and reviews current advances in Let-7-based interventions for GC treatment. It aims to provide foundational insights for a deeper understanding of Let-7-related mechanisms in GC and optimize therapeutic strategies.\u003Cbr>KEYWORDS: Stomach neoplasms; microRNAs; Let-7; carcinogenesis; biomarkers |  |\n\n1 Introduction  \nGastric cancer (GC) is the fifth most prevalent cancer globally and ranks as the fifth leading cause of cancer-related deaths [1]. The majority of patients are diagnosed at advanced stages, which significantly restricts the available treatment options and leads to a poor prognosis [2,3] . GC is characterized by high recurrence, metastasis, and mortality rates, especially in cases with distant spread, where the five-year survival rate is alarmingly low, posing a serious risk to health and life [4] . Conventional treatment strategies for GC mainly consist of surgical removal, chemotherapy, and radiation therapy [4,5] . Although surgical intervention is the primary method for treating GC, its effectiveness diminishes in advanced cases [6,7] . Chemoradiotherapy can serve as an adjuvant to surgery, either enhancing the therapeutic effect before the operation or complementing post-surgical treatment to address potential residual lesions; however, its efficacy is often limited and highly variable, frequently accompanied by a range of adverse events [8,9] . As research into the mechanisms underlying GC progresses, biomolecular therapy has gained attention asa significant area of focus. Although this novel cancer treatment method is gradually becoming a crucial component of GC management, its development continues to encounter numerous challenges [7,10] . Key challenges in the realm of biomolecular therapy for GC include the absence of specific tumor markers, the relative delay in the advancement of molecular targeted therapy compared to other malignancies (such as lung and breast cancer), and the issue of patients developing resistance during biomolecular therapy [11–13] . Overcoming these obstacles is imperative for improving treatment outcomes for GC.  \nCopyright © 2025 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nRecent investigations into the molecular processes involved in GC have increasingly highlighted the role of microRN","cbCaip2WEZy8wGHG","https://ap.wps.com/l/cbCaip2WEZy8wGHG","pdf",3713223,22,"English","# Introduction\n# Overview of the Let-7 Family\n## Classification and Biosynthesis of the Let-7 Family","[{\"question\":\"Why is the Let-7 microRNA family important in gastric cancer?\",\"answer\":\"Let-7 members show aberrant expression in gastric cancer, and their dysregulation is linked to disease progression and patient prognosis. They influence GC by targeting multiple molecular pathways and participating in regulatory mechanisms.\"},{\"question\":\"How do microRNAs such as Let-7 regulate gastric cancer cell behavior?\",\"answer\":\"miRNAs bind complementary sites in the 3′-UTR of target mRNAs, leading to inhibition of translation or promotion of mRNA degradation. Through these target gene effects, they affect processes including proliferation, invasion, and metastasis.\"},{\"question\":\"What does the article focus on regarding therapeutic applications?\",\"answer\":\"The review summarizes expression patterns of the Let-7 family in gastric cancer and reviews advances in Let-7-based interventions. It aims to support improved therapeutic strategies and offer insight for biomarkers and targeted treatment.\"}]","Advances in Expression Regulation, Molecular Targeting Mechanisms, and Therapeutic Applications of the Let-7 MicroRNA Family in Gastric Cancer | PDF",1790174357,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9ebc0be67a0509547ac601be92e3503.webp",983,1271,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f1a4e70c41f3d0044fbbf46b7adeb5f.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a35c1331dec81577aa1277445210db25.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4d7a4b65316043823af66db7c719b14.webp",980,1267]